Skip to main content
← SIGNALS
[OPINION]

Briefing: Large drugmakers are developing fewer antibiotics, analysis finds

Strategic angle: The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.

Editorial StaffMarch 10, 20261 MIN READ

Summary

  • Summary pending editorial review.

Key Facts

Fact Value
Decline in Development 35% decrease in potential antimicrobial treatments
Timeframe Over the past five years

Sources